Search - tctmd.com

Displaying 181 - 200 of 626

Sort: Relevancy | Date

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Daily News

Optimal Care Reported in Less Than Half of Adults With ASCVD

Yael L. Maxwell

December 05, 2023

News Daily News

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

L.A. McKeown

December 01, 2023

Presentation Controversies and Advances 2023

Obesity and Cardiovascular Disease

Presenter: Steven E. Nissen

November 30, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

Presentation TCT 2023

TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Nathan Matzko

October 26, 2023

Presentation TCT 2023

TCT 438: Predictive Value of Abdominal Fat Distribution and Physique Stratified by Body Mass Index on Coronary Artery Disease Severity Using Computed Tomography-derived SYNTAX Score

Presenter: Takuya Miyagi

October 26, 2023

Presentation TCT 2023

TCT 307: Percutaneous Coronary Intervention Outcomes Stratified by Body Mass Index. Are Obesity Classes Created Equally? A Retrospective Population-Based Study

Presenter: Carlos Gaibor

October 26, 2023

Presentation TCT 2023

TCT 298: Bariatric Arterial Embolization: a Mini-invasive Procedure for Treating Obesity

Presenter: Gustavo Samaja

October 26, 2023

Presentation TCT 2023

TCT 13: Metabolic Syndrome, a new predictor of coronary artery calcification burden: An Optical Coherence Tomography Study

Presenter: Francesca Maria Di Muro

October 26, 2023

News Daily News

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Yael L. Maxwell

October 12, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

L.A. McKeown

October 10, 2023

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

Advertisement

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Optimal Care Reported in Less Than Half of Adults With ASCVD

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

Obesity and Cardiovascular Disease

TCTMD’s Top 10 Most Popular Stories for November 2023

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Mortality Risk Varies Among Patients With Very High LDL Levels

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

FDA Grants Tirzepatide a New Indication for Obesity Management

What’s Going to Be Hot at AHA 2023

TCT 508: A Meta-Analysis on the Obesity Paradox in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 438: Predictive Value of Abdominal Fat Distribution and Physique Stratified by Body Mass Index on Coronary Artery Disease Severity Using Computed Tomography-derived SYNTAX Score

TCT 307: Percutaneous Coronary Intervention Outcomes Stratified by Body Mass Index. Are Obesity Classes Created Equally? A Retrospective Population-Based Study

TCT 298: Bariatric Arterial Embolization: a Mini-invasive Procedure for Treating Obesity

TCT 13: Metabolic Syndrome, a new predictor of coronary artery calcification burden: An Optical Coherence Tomography Study

Pooled Cohort Equations Work in Real-world Patients, Even Outliers

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content